Acute chest pain (ACP) is a common symptom that can indicate a range of conditions, from benign to life-threatening. The clinical approach to ACP requires a thorough understanding of differential diagnoses, relevant investigations, and appropriate management strategies.
The initial assessment of a patient presenting with ACP should focus on identifying immediate life-threatening conditions such as myocardial infarction (MI) or aortic dissection. Vital signs, physical examination, and a 12-lead ECG should be performed rapidly. The patient's history, including the characteristics of the pain and risk factors for coronary artery disease, can provide valuable diagnostic clues.
ACP can arise from cardiac, gastrointestinal, pulmonary, musculoskeletal, and psychiatric conditions. Cardiac causes include MI, angina, and pericarditis. Gastrointestinal conditions such as gastroesophageal reflux disease and peptic ulcer disease can mimic cardiac pain. Pulmonary causes include pulmonary embolism and pneumonia. Musculoskeletal and psychiatric causes are often considered once life-threatening conditions have been ruled out.
Investigations should be guided by the suspected diagnosis. For suspected MI, cardiac biomarkers (troponin) and repeated ECGs are essential. Chest radiography, computed tomography, and endoscopy may be indicated for pulmonary and gastrointestinal causes, respectively.
Management depends on the underlying cause. Immediate reperfusion therapy is critical in MI, while aortic dissection requires surgical intervention. Gastrointestinal, pulmonary, musculoskeletal, and psychiatric causes are managed according to their specific treatment guidelines.
The clinical approach to ACP is challenging due to the wide range of potential causes. A systematic approach, guided by a thorough history, physical examination, and appropriate investigations, can help healthcare professionals accurately diagnose and manage these patients. Ongoing education and training in this area are crucial to ensure the best patient outcomes.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation